- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/06 - Dipeptides
Patent holdings for IPC class C07K 5/06
Total number of patents in this class: 797
10-year publication summary
|
30
|
27
|
32
|
54
|
46
|
40
|
36
|
28
|
17
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MedImmune Limited | 617 |
13 |
| Ajinomoto Co., Inc. | 2295 |
12 |
| Ramot at Tel-Aviv University Ltd. | 1477 |
11 |
| Novartis AG | 10744 |
10 |
| Cornell University | 3307 |
8 |
| Suntory Holdings Limited | 2040 |
8 |
| Bristol-myers Squibb Company | 4880 |
7 |
| Takeda Pharmaceutical Company Limited | 2708 |
7 |
| NeoStrata Company, Inc. | 10 |
7 |
| Servier Pharmaceuticals, LLC | 104 |
7 |
| F. Hoffmann-La Roche AG | 7947 |
6 |
| The Regents of the University of California | 19961 |
6 |
| Dana-Farber Cancer Institute, Inc. | 2573 |
6 |
| Medivir AB | 121 |
6 |
| Onyx Therapeutics, Inc. | 69 |
6 |
| The Scripps Research Institute | 1346 |
6 |
| Tokyo Institute of Technology | 1374 |
6 |
| Centre National de La Recherche Scientifique | 10464 |
5 |
| Achillion Pharmaceuticals, Inc. | 164 |
5 |
| Apotex Technologies Inc. | 16 |
5 |
| Other owners | 650 |